Scientists converge in Fargo for the Great Lakes Regional Meeting

May 31, 2000

Research findings ranging from the current health of the Great Lakes to potential anti-cancer properties in food will be presented at the Great Lakes Regional Meeting of the American Chemical Society, the world's largest scientific society, in Fargo, N.D., June 4-6. More than 200 papers will be presented, with nearly 500 scientists expected from the surrounding area.

Research highlights include:

Mom Was Right, Eat Your Veggies: Research indicates that supplementing selenium (Se) in your diet may prevent colon cancer in humans. Regular levels of Se in broccoli do not accumulate in the body as fast as other forms of the compound. The researcher will illustrate how high-Se broccoli is metabolized and may provide increased protection against colon cancer. "Selenium from high-selenium broccoli is protective against colon cancer," J.W. Finley, USDA-ARS Grand Forks Human Nutrition Research Center; Sunday, June 4, 3:30 p.m.

Hair Today, Assessed Tomorrow: Hair analysis is a reliable and effective way to test human exposure to a variety of elements. The research tracks one man over 20 years and the environmental, dietary and occupational variables that can alter the assessment results. "Hair analysis environmental assessment,"D. Christopherson, USDA-ARS Grand Forks Human Nutrition Research Center; Monday, June 5, 9:20 a.m.

Analyzing a DDT Replacement in the Great Lakes: Toxaphene was DDT's replacement in the late 1970s and was commonly used on a variety of crops until it was banned from 1982-86. Toxaphene is still evident in the environment and now contaminates the Great Lakes and the Arctic region. The researcher will present data collected for the past 20 years on the levels of toxaphene in and around the Great Lakes. "Toxaphene in the Great Lakes environment: The application of mass spectrometry for the analysis of extremely complex mixtures," R. Hites, Indiana University, School of Public and Environmental Affairs and Department of Chemistry; Monday, June 5, 10:50 a.m.

WHAT: 32nd Great Lakes Regional Meeting of the American Chemical Society

WHO: Sponsored by the Red River Valley Section of the American Chemical Society

WHEN: Sunday, June 4, through Tuesday, June 6

WHERE: Holiday Inn Conference Center
3803 13th Ave., South
Fargo, N.D.

News media are welcome to attend the meeting. Please see the 32nd Great Lakes Regional Meeting website ( ) or call Hillarie Fogel at 202-872-4371 for more information.
A nonprofit organization with a membership of 161,000 chemists and chemical engineers, the American Chemical Society publishes scientific journals and databases, convenes major research conferences, and provides educational, science policy and career programs in chemistry. Its main offices are in Washington, D.C., and Columbus, Ohio.

American Chemical Society

Related Colon Cancer Articles from Brightsurf:

New prognostic markers for colon cancer identified
The study recently published by MedUni Vienna and collaborative partners nominates ILSs as novel prognostic players orchestrating the pathobiology of metastatic colorectal cancer.

Turning colon cancer cells around
Using a modified natural substance along with current approaches could improve colon cancer treatment, according to findings by University of California, Irvine biologists.

Uncovering the pathway to colon cancer
The hidden world of genetic changes, or mutations, in healthy colon tissue has been uncovered by scientists at the Wellcome Sanger Institute and their collaborators.

Colon cancer growth reduced by exercise
Exercise may play a role in reducing the growth of colon cancer cells according to new research published in The Journal of Physiology.

Towards a better understanding of how colon cancer develops and progresses
Researchers from the University of Luxembourg have discovered a molecular mechanism that is responsible for the spread of cancer cells in the body and the development of metastases in patients with colon cancer.

New target protein for colon cancer identified
Researchers at Boston University School of Medicine (BUSM) have identified a new potential target protein (c-Cbl) they believe can help further the understanding of colon cancer and ultimately survival of patients with the disease.

Colon cancer -- Targeting tumor cell plasticity
Cell type switch helps colon cancer evade treatment, a study suggests.

A bacterial duo linked to colon cancer
Scientists have identified a combination of bacteria that appears to increase the risk of colon cancer.

New model could speed up colon cancer research
Using the CRISPR gene editing system, MIT researchers have shown they can generate colon tumors in mice that very closely resemble human colon tumors, an advance that should allow scientists to learn more about how the disease progresses and also help them test potential new drugs.

Are dialysis patients being over-screened for colon cancer?
Colonoscopies are being performed more often on healthier dialysis patients than on those with more limited life expectancies; however, overall, dialysis patients are being screened at a much higher rate relative to their life expectancy than their counterparts without kidney failure.

Read More: Colon Cancer News and Colon Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to